Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174401 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rocklatan Retinal Perfusion OCT Study

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Oct 2025 to Jan 2026
    • Primary completion date: Oct 2026 to Dec 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.
Trial Details
NCT Number NCT07174401
Lead Sponsor Oregon Health and Science University
Collaborators: Alcon Research
Conditions
(from sponsor)		 Glaucoma
Related terms Glaucoma
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov